<?xml version="1.0" encoding="UTF-8"?>
<ref id="C235">
 <label>235</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Wang</surname>
    <given-names>RR</given-names>
   </name>, 
   <name name-style="western">
    <surname>Yang</surname>
    <given-names>QH</given-names>
   </name>, 
   <name name-style="western">
    <surname>Luo</surname>
    <given-names>RH</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro</article-title>. 
  <source>PLoS One</source>
  <year>2014</year>; 
  <volume>9</volume>: 
  <fpage>e105617</fpage>. doi:
  <pub-id pub-id-type="doi">10.1371/journal.pone.0105617</pub-id>
  <pub-id pub-id-type="pmid">25144636</pub-id>
 </mixed-citation>
</ref>
